LifeForce Hospitals

02.gif (21371 bytes)

Home
Clinical Trials
Chemical Trials
Vitamin Info
Neurotoxins
Plankton Research
Life-Span Extension

Products in Development

LifeForce currently has three drug candidates in clinical
trials. Amyloxine® is being developed for the potential treatment of Carcinoma (Cancer). Rotan® is being developed for the potential treatment of Arthritus. A third product, MD-Amylox®   is being developed for the potential treatment of ARMD Macular Degeneration (Dry Type). CA-Amyline® is being developed for the potential treatment of Coronary Artery Disease..


pipeline.gif (4766 bytes)

  Clinical trials being conducted 

by LifeForce Hospitals Research

| Amyloxine® | Rotan® | MD-Amylox® |  | CA-Amyline® |Disclosure

 
Home ] Clinical Trials ] Chemical Trials ] Vitamin Info ] Neurotoxins ] Plankton Research ] Life-Span Extension ]

 

Send mail to medmail@usa.net with questions or comments about this web site.
Copyright © 1999 LifeForce Hospitals Webserver Location Italy